Your browser doesn't support javascript.
loading
The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn's Disease With Poor Prognostic Factors: The MODIFY Study.
Mantzaris, Gerassimos J; Zeglinas, Christos; Theodoropoulou, Angeliki; Koutroubakis, Ioannis; Orfanoudaki, Eleni; Katsanos, Konstantinos; Christodoulou, Dimitrios; Michalopoulos, Georgios; Tzouvala, Maria; Moschovis, Dimitrios; Michopoulos, Spyridon; Zampeli, Evanthia; Soufleris, Konstantinos; Ilias, Anastasios; Chatzievangelinou, Christina; Kyriakakis, Antonios; Antachopoulou, Konstantia; Karmiris, Konstantinos.
Afiliação
  • Mantzaris GJ; Department of Gastroenterology, General Hospital of Athens "Evaggelismos", Athens, Greece.
  • Zeglinas C; Medical Department, AbbVie Pharmaceuticals S.A., Athens, Greece.
  • Theodoropoulou A; Department of Gastroenterology, General Hospital of Heraklion "Venizeleio-Pananeio", Heraklion, Crete, Greece.
  • Koutroubakis I; Department of Gastroenterology, University Hospital of Heraklion, Crete, Greece.
  • Orfanoudaki E; Department of Gastroenterology, University Hospital of Heraklion, Crete, Greece.
  • Katsanos K; Department of Gastroenterology, Pathology Unit, University General Hospital of Ioannina, Ioannina, Greece.
  • Christodoulou D; Department of Gastroenterology, Pathology Unit, University General Hospital of Ioannina, Ioannina, Greece.
  • Michalopoulos G; Department of Gastroenterology, General Hospital of Piraeus "Tzaneio", Piraeus, Greece.
  • Tzouvala M; Department of Gastroenterology, General Hospital of Nikaia & Piraeus "Agios Panteleimon"-General Hospital Dytikis Attikis "Agia Varvara", Nikaia, Greece.
  • Moschovis D; Department of Gastroenterology, General Hospital of Nikaia & Piraeus "Agios Panteleimon"-General Hospital Dytikis Attikis "Agia Varvara", Nikaia, Greece.
  • Michopoulos S; Department of Gastroenterology, Pathology Unit, General Hospital of Athens "Alexandra", Athens, Greece.
  • Zampeli E; Department of Gastroenterology, Pathology Unit, General Hospital of Athens "Alexandra", Athens, Greece.
  • Soufleris K; Department of Gastroenterology-Oncology, Pathology Unit, Anticancer Hospital of Thessaloniki "Theageneio", Thessaloniki, Greece.
  • Ilias A; Department of Gastroenterology, Pathology Unit, General Hospital of Thessaloniki "G. Papanikolaou", Thessaloniki, Greece.
  • Chatzievangelinou C; Department of Gastroenterology, General Hospital of Athens "Evaggelismos", Athens, Greece.
  • Kyriakakis A; Medical Department, AbbVie Pharmaceuticals S.A., Athens, Greece.
  • Antachopoulou K; Medical Department, AbbVie Pharmaceuticals S.A., Athens, Greece.
  • Karmiris K; Department of Gastroenterology, General Hospital of Heraklion "Venizeleio-Pananeio", Heraklion, Crete, Greece.
Crohns Colitis 360 ; 3(4): otab064, 2021 Oct.
Article em En | MEDLINE | ID: mdl-36777275
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Crohns Colitis 360 Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Crohns Colitis 360 Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia